Drug ID: | NPD5365 |
Drug Name: | SQ109 |
Molecular Formula: | C22H38N2 |
Canonical SMILES: | C/C(=CCNCCNC1C2CC3CC1CC(C2)C3)/CCC=C(C)C |
Standard InCHI: | InChI=1S/C22H38N2/c1-16(2)5-4-6-17(3)7-8-23-9-10-24-22-20-12-18-11-19(14-20)15-21(22)13-18/h5,7,18-24H,4,6,8-15H2,1-3H3/b17-7+ |
Standard InCHIKey: | JFIBVDBTCDTBRH-REZTVBANSA-N |
Max Developmental Stage: | Phase 2 |
Max Developmental Stage Source: | DrugBank |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB003852 |
DrugBank | DB05186 |
ChEMBL | CHEMBL561057 |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 5274428 |
ChEBI | |
CAS Number | 502487-67-4 |
Molecular Weight | 330.30 |
ALogP | 1.0196 |
MLogP | 3.66 |
XLogP | 5.219 |
HDA | 2 |
HBD | 2 |
Rotatable Bonds | 12 |
TPSA | 24.06 |
RO5 Violation | 1 |